Clinical Trials

NCT02261688 | TERMINATED | NA

9 participants

Salt and TH-17 in Healthy Human Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2014-03-31

Completion:

2019-07-31

Conditions

• Th17 Helper Immune Cells
• Autoimmunity
• Salt Intake
• Sodium Chloride

Interventions

• DIETARY_SUPPLEMENT

No Results Yet

NCT02224794 | COMPLETED

250 participants

LIFE Study: Least Invasive Fast-Track EVAR

Study Type:

OBSERVATIONAL

Last Updated:

2021-06-08

Start Date:

2014-09-30

Completion:

2016-06-30

Conditions

• Abdominal Aortic Aneurysm

Interventions

• DEVICE

No Results Yet

NCT02060526 | COMPLETED | PHASE2

21 participants

Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2014-02-26

Completion:

2016-06-01

Conditions

• Sanfilippo Syndrome

Interventions

• DRUG

Results Available

NCT02046291 | COMPLETED | PHASE1

21 participants

Safety of Romiplostim (Nplate®) Following UCBT

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2015-04-10

Completion:

2020-12-12

Conditions

• Hematologic Malignancies

Interventions

• DRUG

No Results Yet

NCT02009332 | COMPLETED | PHASE1/PHASE2

21 participants

Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2014-04-09

Completion:

2019-12-01

Conditions

• Non-muscle Invasive Bladder Cancer (NMIBC)

Interventions

• DRUG

Results Available

NCT01919801 | COMPLETED | PHASE3

118 participants

Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2013-12-02

Completion:

2015-08-22

Conditions

• Angiotensin Converting Enzyme Inhibitor Induced Angioedema

Interventions

• DRUG

Results Available

NCT01806584 | TERMINATED | PHASE2

32 participants

An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis Access

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2013-03-28

Completion:

2014-10-23

Conditions

• Arteriovenous Graft

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT01806545 | COMPLETED | PHASE2

64 participants

An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2013-03-26

Completion:

2014-10-27

Conditions

• Arteriovenous Fistula

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT01718483 | COMPLETED | PHASE3

383 participants

SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2012-11-26

Completion:

2013-09-25

Conditions

• Binge Eating Disorder

Interventions

• DRUG

Results Available

NCT01667406 | COMPLETED | PHASE2

175 participants

The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2012-06-01

Completion:

2016-10-11

Conditions

• Infertility

Interventions

• DRUG

Results Available

NCT01642212 | COMPLETED | PHASE2

93 participants

OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2012-07-23

Completion:

2014-10-30

Conditions

• Eosinophilic Esophagitis (EoE)

Interventions

• DRUG

Results Available

NCT01626833 | COMPLETED | PHASE2/PHASE3

15 participants

Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2013-03-31

Completion:

2021-03-31

Conditions

• Anorexia Nervosa
• Interruption of Growth
• Delayed Puberty
• Osteopenia With Failure of Acquisition of Bone Mass

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT01624506 | COMPLETED

760 participants

Observational Study of Anti-Reflux Surgery

Study Type:

OBSERVATIONAL

Last Updated:

2021-06-08

Start Date:

2010-01-31

Completion:

2015-01-31

Conditions

• GERD
• Gastroesophageal Reflux
• Gastro Esophageal Reflux

Results Available

NCT01564485 | COMPLETED | NA

193 participants

Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2008-07-31

Completion:

2016-12-31

Conditions

• Diabetes
• Metabolic Syndrome

Interventions

• DIAGNOSTIC_TEST
• BEHAVIORAL

Results Available

NCT01552915 | COMPLETED | PHASE4

464 participants

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2012-04-17

Completion:

2014-01-22

Conditions

• Attention-deficit/Hyperactivity Disorder

Interventions

• DRUG

Results Available

NCT01540474 | COMPLETED | PHASE1

36 participants

Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2012-02-29

Completion:

2012-10-31

Conditions

• Malaria

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT01518946 | COMPLETED | PHASE4

24 participants

Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2012-05-14

Completion:

2013-06-22

Conditions

• Orthostatic Hypotension

Interventions

• DRUG

Results Available

NCT01483144 | COMPLETED | PHASE3

171 participants

Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2013-10-31

Completion:

2018-11-30

Conditions

• Familial Adenomatous Polyposis

Interventions

• DRUG

Results Available

NCT01433991 | TERMINATED | PHASE1/PHASE2

30 participants

A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2011-10-13

Completion:

2015-03-18

Conditions

• Advanced Solid Tumors

Interventions

• DRUG

Results Available

NCT01386658 | COMPLETED | PHASE3

32 participants

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2012-01-27

Completion:

2018-03-12

Conditions

• Hereditary Angioedema (HAE)

Interventions

• DRUG

Results Available

NCT01298141 | COMPLETED | PHASE3

171 participants

A Multicenter Open-Label Treatment Protocol to Observe the Safety of Replagal (Agalsidase Alfa) Enzyme Replacement Therapy in Canadian Patients With Fabry Disease

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2011-08-10

Completion:

2017-09-25

Conditions

• Fabry Disease

Interventions

• BIOLOGICAL

Results Available

NCT01136668 | TERMINATED | NA

13 participants

Transversus Abdominis Plane Block in Children Undergoing Ostomy Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2010-04-30

Completion:

2012-05-31

Conditions

• Anesthesia
• Ostomy

Interventions

• PROCEDURE

Results Available

NCT01124643 | COMPLETED | PHASE3

35 participants

Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2010-04-13

Completion:

2013-07-08

Conditions

• Fabry Disease

Interventions

• BIOLOGICAL

Results Available

NCT01059526 | COMPLETED

81 participants

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

Study Type:

OBSERVATIONAL

Last Updated:

2021-06-08

Start Date:

2010-02-01

Completion:

2013-09-01

Conditions

• Hereditary Angioedema (HAE)

Interventions

• DRUG

Results Available

NCT01028105 | TERMINATED | NA

975 participants

Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2008-02-29

Completion:

2011-01-31

Conditions

• Methicillin-resistant Staphylococcus Aureus Infection

Interventions

• OTHER

No Results Yet

NCT00997984 | COMPLETED | PHASE3

340 participants

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2009-11-17

Completion:

2010-10-09

Conditions

• Attention-Deficit/Hyperactivity Disorder

Interventions

• DRUG

Results Available

NCT00985725 | COMPLETED | PHASE2

143 participants

SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2009-10-29

Completion:

2011-04-18

Conditions

• Major Depressive Disorder

Interventions

• DRUG

Results Available

NCT00882921 | COMPLETED

26 participants

An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients

Study Type:

OBSERVATIONAL

Last Updated:

2021-06-08

Start Date:

2008-10-14

Completion:

2013-02-08

Conditions

• Hunter Syndrome

Interventions

• BIOLOGICAL

Results Available

NCT00681811 | TERMINATED | PHASE2

11 participants

Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2008-02-20

Completion:

2010-10-22

Conditions

• Late Infantile Metachromatic Leukodystrophy

Interventions

• DRUG

Results Available

NCT00616759 | COMPLETED | NA

20 participants

The Effect on Cognition of Terminating ECT Induced Seizures With Propofol

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2006-09-30

Completion:

2010-03-24

Conditions

• Major Depression

Interventions

• PROCEDURE
• DRUG

Results Available

NCT00607386 | COMPLETED | PHASE4

28 participants

Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2007-12-31

Completion:

2011-07-08

Conditions

• Hunter Syndrome
• Mucopolysaccharidosis II
• MPS II

Interventions

• BIOLOGICAL

Results Available

NCT00553631 | COMPLETED | PHASE3

34 participants

Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2008-01-29

Completion:

2009-05-05

Conditions

• Gaucher Disease, Type 1

Interventions

• BIOLOGICAL

Results Available

NCT00528658 | COMPLETED | PHASE2

782 participants

Cost-effectiveness of Two Painkillers for Treating Pain After Limb Injuries

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2005-01-31

Completion:

2008-12-31

Conditions

• Soft Tissue Injuries

Interventions

• DRUG

No Results Yet

NCT00507065 | COMPLETED | PHASE3

329 participants

Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2003-05-28

Completion:

2004-03-24

Conditions

• ADHD

Interventions

• DRUG

No Results Yet

NCT00506727 | COMPLETED | PHASE4

215 participants

Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2003-08-05

Completion:

2004-07-02

Conditions

• ADHD

Interventions

• DRUG

No Results Yet

NCT00462709 | COMPLETED | PHASE3

146 participants

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2006-06-27

Completion:

2009-03-31

Conditions

• Hereditary Angioedema

Interventions

• BIOLOGICAL

Results Available

NCT00457015 | COMPLETED | PHASE3

96 participants

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2007-04-01

Completion:

2008-06-01

Conditions

• Hereditary Angioedema (HAE)

Interventions

• DRUG

Results Available

NCT00456508 | COMPLETED | PHASE3

147 participants

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2007-04-01

Completion:

2010-06-01

Conditions

• Hereditary Angioedema (HAE)

Interventions

• DRUG

Results Available

NCT00438815 | COMPLETED | PHASE3

113 participants

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2006-09-21

Completion:

2009-03-31

Conditions

• Hereditary Angioedema

Interventions

• BIOLOGICAL

Results Available

NCT00414765 | COMPLETED | PHASE4

26 participants

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Study Type:

INTERVENTIONAL

Last Updated:

2021-06-08

Start Date:

2008-09-03

Completion:

2010-03-28

Conditions

• Metastatic Renal Cell Carcinoma
• Metastatic Melanoma

Interventions

• DRUG

Results Available